To minimize its severe side effects, low taxol doses (100 nM) along with Bcl-2 siRNA have been assayed [334]; both Bcl-2 mRNA and the expressed protein were decreased in human glioblastoma U138 and U251 cell lines. Here, BCL2 is linked to glioblastoma.